Patents by Inventor Erik Miljan

Erik Miljan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of limb ischemia
    Patent number: 9410122
    Abstract: The present invention uses neural stem cells in the manufacture of a medicament for the treatment of a patient suffering peripheral arterial disease. The invention is particularly suited for treating limb ischemia or Buerger's disease.
    Type: Grant
    Filed: August 4, 2014
    Date of Patent: August 9, 2016
    Assignee: RENEURON LIMITED
    Inventors: John Sinden, Erik Miljan, Paolo Madeddu
  • Cellular compositions for use in therapy
    Patent number: 9265795
    Abstract: The present invention provides a therapeutic composition comprising: (i) Trolox, Na+, K+, Ca2+, Mg2+, Cl?, H2PO4?, HEPES, lactobionate, sucrose, mannitol, glucose, dextran-40, adenosine, glutathione; and (ii) stem cells or progenitor cells, wherein the composition does not comprise a dipolar aprotic solvent, in particular DMSO. The present invention also relates to methods of formulating said composition for cryopreservation and subsequent direct administration to a patient, and medicaments comprising said composition.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: February 23, 2016
    Assignee: RENEURON LIMITED
    Inventors: Andrew Hope, Erik Miljan, John Sinden
  • Treatment of limb ischemia
    Patent number: 8932577
    Abstract: The present invention uses neural stem cells in the manufacture of a medicament for the treatment of a patient suffering peripheral arterial disease. The invention is particularly suited for treating limb ischemia or Buerger's disease.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: January 13, 2015
    Assignee: Reneuron Limited
    Inventors: John Sinden, Erik Miljan, Paolo Madeddu
  • TREATMENT OF LIMB ISCHEMIA
    Publication number: 20140341868
    Abstract: The present invention uses neural stem cells in the manufacture of a medicament for the treatment of a patient suffering peripheral arterial disease. The invention is particularly suited for treating limb ischemia or Buerger's disease.
    Type: Application
    Filed: August 4, 2014
    Publication date: November 20, 2014
    Inventors: JOHN SINDEN, ERIK MILJAN, PAOLO MADEDDU
  • TREATMENT OF LIMB ISCHEMIA
    Publication number: 20120093786
    Abstract: The present invention uses neural stem cells in the manufacture of a medicament for the treatment of a patient suffering peripheral arterial disease. The invention is particularly suited for treating limb ischemia or Buerger's disease.
    Type: Application
    Filed: February 5, 2010
    Publication date: April 19, 2012
    Applicant: RENEURON LIMITED
    Inventors: John Sinden, Erik Miljan, Paolo Madeddu
  • CELLULAR COMPOSITIONS FOR USE IN THERAPY
    Publication number: 20120076854
    Abstract: The present invention provides a therapeutic composition comprising: (i) Trolox, Na+, K+, Ca2+, Mg2+, Cl?, H2PO4?, HEPES, lactobionate, sucrose, mannitol, glucose, dextran-40, adenosine, glutathione; and (ii) stem cells or progenitor cells, wherein the composition does not comprise a dipolar aprotic solvent, in particular DMSO. The present invention also relates to methods of formulating said composition for cryopreservation and subsequent direct administration to a patient, and medicaments comprising said composition.
    Type: Application
    Filed: December 7, 2009
    Publication date: March 29, 2012
    Applicant: Reneuron Limited
    Inventors: Andrew Hope, Erik Miljan, John Sinden
  • Conditionally-Immortalised Pancreatic Cells
    Publication number: 20090238799
    Abstract: Conditionally immortalized pancreatic cells are produced which remain immortal in the presence of 4-hydroxytamoxifen (4-OHT) but express normal pancreatic cell markers when 4-OHT is not present. The cells therefore permit cell lines to be constructed to produce cells useful for transplantation or in screening assays.
    Type: Application
    Filed: November 3, 2006
    Publication date: September 24, 2009
    Inventors: John Sinden, Lara Stevanato, Erik Miljan